ACQUIREDT+30
Lappe Mark
Inhibrx Biosciences Inc · NASDAQ
+1,500 sh · $148.3K
Filed 28 Sept 2026SEC Form 4view source
Viking Global Investors
13F filer
$106.5M
1,123,929 sh
BlackRock
13F filer
$9.7M
683,075 sh
Renaissance Technologies
13F filer
$3.4M
50,183 sh
Kayyem Jon Faiz
US insider
$500.0K
15,000 sh
Lappe Mark
US insider
$305.1K
35,000 sh
Forsyth Douglas
US insider
$286.6K
2,500 sh
Lappe Mark
Inhibrx Biosciences Inc · NASDAQ
+1,500 sh · $148.3K
Lappe Mark
Inhibrx Biosciences Inc · NASDAQ
+2,176 sh · $216.7K
Lappe Mark
Inhibrx Biosciences Inc · NASDAQ
+3,000 sh · $305.1K
Lappe Mark
Inhibrx Biosciences Inc · NASDAQ
+3,324 sh · $328.6K
Kayyem Jon Faiz
Inhibrx Biosciences Inc · NASDAQ
+5,000 sh · $500.0K
Kayyem Jon Faiz
Inhibrx Biosciences Inc · NASDAQ
+5,000 sh · $500.0K
Manhard Kimberly
Inhibrx Biosciences Inc · NASDAQ
−500 sh · $52.5K
Manhard Kimberly
Inhibrx Biosciences Inc · NASDAQ
−500 sh · $55.9K
Manhard Kimberly
Inhibrx Biosciences Inc · NASDAQ
−500 sh · $55.1K
Manhard Kimberly
Inhibrx Biosciences Inc · NASDAQ
−500 sh · $57.9K